396 related articles for article (PubMed ID: 27864247)
1. Impact of a pharmacist-delivered discharge and follow-up intervention for patients with acute coronary syndromes in Qatar: a study protocol for a randomised controlled trial.
Zidan A; Awaisu A; Kheir N; Mahfoud Z; Kaddoura R; AlYafei S; El Hajj MS
BMJ Open; 2016 Nov; 6(11):e012141. PubMed ID: 27864247
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of a structured pharmacist-delivered intervention for patients post-acute coronary syndromes on all-cause hospitalizations and cardiac-related hospital readmissions: a prospective quasi-experimental study.
El Hajj MS; Kaddoura R; Abu Yousef SEA; Orabi B; Awaisu A; AlYafei S; Shami R; Mahfoud ZR
Int J Clin Pharm; 2023 Jun; 45(3):630-640. PubMed ID: 36795303
[TBL] [Abstract][Full Text] [Related]
3. Utilization of Evidence-Based Secondary Prevention Medications at the Time of Discharge in Patients with Acute Coronary Syndrome (ACS) in Qatar.
El-Hajj MS; Saad A; Al-Suwaidi J; Al-Marridi WZ; Elkhalifa DH; Mohamed AA; Mahfoud ZR
Curr Vasc Pharmacol; 2016; 14(4):394-403. PubMed ID: 26916397
[TBL] [Abstract][Full Text] [Related]
4. The impact of pharmacist-initiated interventions in improving acute coronary syndrome secondary prevention pharmacotherapy prescribing upon discharge.
Hassan Y; Kassab Y; Abd Aziz N; Akram H; Ismail O
J Clin Pharm Ther; 2013 Apr; 38(2):97-100. PubMed ID: 23441979
[TBL] [Abstract][Full Text] [Related]
5. Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge.
Lee HY; Cooke CE; Robertson TA
J Manag Care Pharm; 2008 Apr; 14(3):271-80. PubMed ID: 18439049
[TBL] [Abstract][Full Text] [Related]
6. Association between in-hospital guideline adherence and postdischarge major adverse outcomes of patients with acute coronary syndrome in Vietnam: a prospective cohort study.
Nguyen T; Le KK; Cao HTK; Tran DTT; Ho LM; Thai TND; Pham HTK; Pham PT; Nguyen TH; Hak E; Pham TT; Taxis K
BMJ Open; 2017 Oct; 7(10):e017008. PubMed ID: 28982823
[TBL] [Abstract][Full Text] [Related]
7. Effect of evidence-based cardiac drug therapy on mortality in patients with acute coronary syndrome: Findings from the Gulf COAST registry.
Al-Zakwani I; Zubaid M; Alsheikh-Ali AA; Almahmeed W; Rashed W
Cardiovasc Ther; 2018 Dec; 36(6):e12463. PubMed ID: 30079461
[TBL] [Abstract][Full Text] [Related]
8. Effect of pharmacist care on medication adherence and cardiovascular outcomes among patients post-acute coronary syndrome: A systematic review.
El Hajj MS; Jaam MJ; Awaisu A
Res Social Adm Pharm; 2018 Jun; 14(6):507-520. PubMed ID: 28641999
[TBL] [Abstract][Full Text] [Related]
9. Impact of a clinical pharmacist on optimising the quality use of medicines according to the acute coronary syndrome (ACS) secondary prevention guidelines and medication adherence following discharge in patients with ACS in Sri Lanka: a prospective non-randomised controlled trial study protocol.
Bagyawantha NMY; Coombes ID; Gawarammana I; Fahim M
BMJ Open; 2023 Feb; 13(2):e059413. PubMed ID: 36759028
[TBL] [Abstract][Full Text] [Related]
10. Impact of Optimal Medical Therapy at Discharge on One-year Direct Medical Costs in Patients with Acute Coronary Syndromes: A Retrospective, Observational Database Analysis in China.
He X; Wang Y; Cong H; Lu C; Wu J
Clin Ther; 2019 Mar; 41(3):456-465.e2. PubMed ID: 30770126
[TBL] [Abstract][Full Text] [Related]
11. Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study.
Bi Y; Gao R; Patel A; Su S; Gao W; Hu D; Huang D; Kong L; Qi W; Wu Y; Yang Y; Turnbull F;
Am Heart J; 2009 Mar; 157(3):509-516.e1. PubMed ID: 19249422
[TBL] [Abstract][Full Text] [Related]
12. Reasons for discontinuation of recommended therapies according to the patients after acute coronary syndromes.
Gencer B; Rodondi N; Auer R; Räber L; Klingenberg R; Nanchen D; Carballo D; Vogt P; Carballo S; Meyer P; Matter CM; Windecker S; Lüscher TF; Mach F
Eur J Intern Med; 2015 Jan; 26(1):56-62. PubMed ID: 25582072
[TBL] [Abstract][Full Text] [Related]
13. Impact of pharmacist intervention in conjunction with outpatient physician follow-up visits after hospital discharge on readmission rate.
Arnold ME; Buys L; Fullas F
Am J Health Syst Pharm; 2015 Jun; 72(11 Suppl 1):S36-42. PubMed ID: 25991594
[TBL] [Abstract][Full Text] [Related]
14. Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome.
Yan AT; Yan RT; Tan M; Huynh T; Soghrati K; Brunner LJ; DeYoung P; Fitchett DH; Langer A; Goodman SG;
Am Heart J; 2007 Dec; 154(6):1108-15. PubMed ID: 18035083
[TBL] [Abstract][Full Text] [Related]
15. Effect of Pharmacist Counseling Intervention on Health Care Utilization Following Hospital Discharge: A Randomized Control Trial.
Bell SP; Schnipper JL; Goggins K; Bian A; Shintani A; Roumie CL; Dalal AK; Jacobson TA; Rask KJ; Vaccarino V; Gandhi TK; Labonville SA; Johnson D; Neal EB; Kripalani S;
J Gen Intern Med; 2016 May; 31(5):470-7. PubMed ID: 26883526
[TBL] [Abstract][Full Text] [Related]
16. Impact of pharmacist-led medication management in care transitions.
Yang S
BMC Health Serv Res; 2017 Nov; 17(1):722. PubMed ID: 29132369
[TBL] [Abstract][Full Text] [Related]
17. Optimizing prevention and guideline-concordant care in Montenegro.
Knežević B; Musić L; Batrićević G; Bošković A; Bulatović N; Nenezić A; Vujović J; Kalezić M
Int J Cardiol; 2016 Aug; 217 Suppl():S32-6. PubMed ID: 27381861
[TBL] [Abstract][Full Text] [Related]
18. In-hospital management and mortality in elderly patients with non-ST-segment elevation acute coronary syndromes treated in centers without on-site invasive facilities.
Dziewierz A; Siudak Z; Rakowski T; Zdzienicka J; Dykla D; Mielecki W; Dubiel JS; Dudek D
Cardiol J; 2008; 15(5):451-7. PubMed ID: 18810721
[TBL] [Abstract][Full Text] [Related]
19. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
Vermeer NS; Bajorek BV
J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
[TBL] [Abstract][Full Text] [Related]
20. [Impact of different intervention models on adherence to secondary prevention therapies in patients with acute coronary syndrome].
Liu J; Wang W; Liu J; Wang Y; Qi Y; Sun JY; Zhao D
Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Feb; 46(2):124-130. PubMed ID: 29495236
[No Abstract] [Full Text] [Related]
[Next] [New Search]
